Subrata Shaw
About Subrata Shaw
Subrata Shaw is a Research Scientist II and Project Lead at the Broad Institute of MIT and Harvard, where he has worked since 2020. He has extensive experience in drug discovery and project management, having previously held positions at various prestigious institutions including Vanderbilt University Medical Center and Oregon State University.
Current Role at Broad Institute
Subrata Shaw serves as Research Scientist II and Project Lead at the Broad Institute of MIT and Harvard since 2020. In this role, he manages an annual budget exceeding 5 million dollars for oncology-focused drug discovery projects. He leads a diverse team of experts from various scientific disciplines, including pharmacology, biochemistry, biophysics, chemistry, protein science, and structural and computational biology. His responsibilities include providing scientific guidance to pharmaceutical partners and overseeing the progress of multiple projects.
Previous Experience at Broad Institute
Prior to his current position, Subrata Shaw worked at the Broad Institute as Research Scientist I and Project Lead from 2017 to 2020. During this time, he contributed to the development of clinical candidates across various therapeutic areas. His experience at Broad Institute has been integral to his professional growth in the field of drug discovery.
Academic Background
Subrata Shaw completed his Doctor of Philosophy (PhD) in Organic Chemistry at Oregon State University from 2007 to 2013. He also holds a Master of Science (M.S.) in Chemistry from the Indian Institute of Technology, Kanpur, where he studied from 2005 to 2007. His undergraduate studies were completed at Calcutta University, where he earned a Bachelor of Science (B.S.) in Chemistry from 2002 to 2005.
Research and Mentorship Experience
Throughout his career, Subrata Shaw has held various research positions, including roles as a Doctoral Researcher and Teaching Assistant at Oregon State University from 2007 to 2014, and as a BRET Postdoctoral Fellow at Vanderbilt University Medical Center from 2014 to 2017. He actively mentors junior team members and guides their career development, managing two direct reports at the bench. His leadership in research projects emphasizes his commitment to fostering talent in the scientific community.
Focus on Drug Discovery
Subrata Shaw's work primarily focuses on improving ADME (Absorption, Distribution, Metabolism, and Excretion) parameters during the lead optimization stage for pharmacokinetics (PK) and pharmacodynamics (PD) modulation. He has led six projects across four therapeutic areas, contributing to the advancement of drug candidates in the oncology field. His expertise in drug discovery is complemented by his ability to collaborate with multidisciplinary teams to achieve project goals.